PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
38.72%
Revenue growth above 1.5x VMC's 5.09%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
380.04%
Gross profit growth above 1.5x VMC's 5.47%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2200.72%
EBIT growth above 1.5x VMC's 7.80%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
2200.72%
Operating income growth above 1.5x VMC's 7.80%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
272.22%
Net income growth above 1.5x VMC's 17.52%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
276.92%
EPS growth above 1.5x VMC's 17.19%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
276.92%
Diluted EPS growth above 1.5x VMC's 17.19%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.23%
Share count expansion well above VMC's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
292.55%
10Y revenue/share CAGR above 1.5x VMC's 185.58%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
88.75%
5Y revenue/share CAGR 1.25-1.5x VMC's 64.52%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
121.56%
3Y revenue/share CAGR above 1.5x VMC's 18.76%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
516.49%
Net income/share CAGR above 1.5x VMC's 143.54% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
89.69%
5Y net income/share CAGR above 1.5x VMC's 4.86%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-23.58%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while VMC invests at 1.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.